Effects of long-term cryopreservation of PBMC on recovery of B cell subpopulations

J Immunol Methods. 2021 Aug:495:113081. doi: 10.1016/j.jim.2021.113081. Epub 2021 May 26.

Abstract

Cryopreservation of human peripheral blood mononuclear cells (PBMC) is used in many clinical and research applications to avoid direct and on-site analysis of samples. Storage of PBMC further allows prequalification of donor cells for routine laboratory methods involving the evaluation of immune responses. Previous studies reported changes in cellular composition and phenotype of PBMC following the freezing procedure. In our 12-month follow-up study, we focused on B cells and proportional representation of B cell subpopulations during long-term storage at -80 °C. Over the 12-month period, we observed a gradual decline in B cell viability and recovery. Notably, no changes in the proportional representation of human B cell subpopulations occurred in this period and the functional response elicited by antigen and TLR9 ligand CpG remained comparable to that observed after short-term storage for one month.

Keywords: B cells; Cryopreservation; Human; Memory B cells; PBMC.

Publication types

  • Comparative Study
  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • B-Lymphocytes / drug effects
  • B-Lymphocytes / immunology*
  • B-Lymphocytes / metabolism
  • Cell Separation*
  • Cell Survival
  • Cells, Cultured
  • Cryopreservation*
  • Feasibility Studies
  • Humans
  • Immunoglobulin G / metabolism
  • Immunologic Memory*
  • Ligands
  • Oligodeoxyribonucleotides / pharmacology
  • Phenotype
  • Tetanus Toxoid / pharmacology
  • Time Factors
  • Toll-Like Receptor 9 / agonists
  • Toll-Like Receptor 9 / metabolism

Substances

  • CPG-oligonucleotide
  • Immunoglobulin G
  • Ligands
  • Oligodeoxyribonucleotides
  • TLR9 protein, human
  • Tetanus Toxoid
  • Toll-Like Receptor 9